Can a smartphone app help prevent suicide? new study investigates
NCT ID NCT05427734
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tested a mobile app called WisePath designed to help adults who are thinking about suicide and may also misuse alcohol. Over 12 weeks, 127 participants either used the WisePath app or received standard self-help resources. Researchers measured changes in suicidal thoughts, coping skills, and alcohol use to see if the app provided extra support.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
127 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Nov 2025
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
22 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Resides in the United States * 22+ years of age * English speaking * At risk for suicide, as evidenced by at least one of the following: * One or more lifetime suicide attempts (ASQ item 4) * Endorsement of any ASQ items 1 -3 (expanded from "past few weeks" in ASQ to "past 30 days" in our measures) * Item 1: In the past 30 days, have you wished you were dead? * Item 2: In the past 30 days, have you felt that you or your family would be better off if you were dead? * Item 3: In the 30 days, have you been having thoughts about killing yourself? * Currently has a primary care provider and sought care from them in the past year * Possesses and is the primary user of an Android- or iPhone-based smartphone with a data plan Given that alcohol misuse exponentially increases the risk of death by suicide, can exacerbate other problems, and interfere with effective treatment, we will over-recruit individuals who misuse alcohol to ensure relevance of the tool for them. No fewer than 35% of the sample will be comprised of individuals who score 8 or more on the Alcohol Use Disorders Identification Test (AUDIT), indicating a harmful or hazardous level of drinking. To ensure a sufficient sample of individuals who misuse alcohol, no fewer than 35% of the sample will be comprised of individuals who score 8 or more on the Alcohol Use Disorders Identification Test (AUDIT), indicating a harmful or hazardous level of drinking. Exclusion Criteria: * Severe depression (PHQ-9 score of 20 or greater) * Alcohol dependence (AUDIT score of 32 or greater) * Acutely suicidal (affirms item 5 of the Ask Suicide Screening Questions; Are you having thoughts of killing yourself right now? Followed by endorsing intent; Have you intended to act on urges to kill yourself in the past 30 days? or planning within the past 30 days; Have you made a plan to kill yourself in the past 30 days?) * Significant drug abuse problems (scores 6 or greater on the DAST-10) Individuals who are excluded because of the severity of their depression, suicide acuity, and/or degree of substance use disorder will be provided with resources (i.e., the Suicide and Crisis Lifeline (988), SAMHSA's National Helpline) and encouraged to reach out to their primary care or mental/behavioral health provider.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alcohol abuse are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Evidence-Based Practice Institute, Inc.
Seattle, Washington, 98126, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Investigating the Mu:Kappa opioid receptor imbalance in alcohol use disorder
- Identification of cellular and molecular mechanisms involved in the pathophysiology of alcohol use disorder by examination of cerebrospinal fluid
- Intravenous acetate as an adjunctive treatment for alcohol withdrawal in hospitalized patients
- Intramuscular ketamine for suicidal patients in the evanston hospital emergency department for suicidal distress: a pilot study
- Can a gentle brain current quiet alcohol cravings?
- A two-hour talk might boost prostate cancer screening rates